NEW INSIGHTS FROM THE PHASE III SUNLIGHT TRIAL
6 May 2026
Enhancing clinical cancer research through the sharing of data and biospecimens
At MediMix, we are dedicated to keeping Belgian healthcare professionals at the forefront of medicine. Our team brings you high-value insights from leading congresses worldwide, across key disease areas including oncology. In collaboration with Belgian and international experts, we transform the latest data into practical knowledge.
Congress reports
Now live
Coming soon
Now live
Now live
Coming soon
Coming soon
Coming soon
Past congresses
What's New Doc?
Latest publications
PHASE 3B ProvIDHe
6 May 2026
Ivosidenib for IDH1-mutant, advanced cholangiocarcinoma Real-world data from the phase 3b ProvIDHe study
KEYNOTE-024
6 May 2026
Durable survival withpembrolizumab monotherapy in metastatic NSCLC with high levels of PD-L1 expression
Enhancing clinical cancer research through sharing of data and biospecimens
6 May 2026
Enhancing clinical cancer research through the sharing of data and biospecimens
DESTINY-Breast03 trial
6 May 2026
Trastuzumab deruxtecan solidifi ed as preferred 2nd line treatment for patients with HER2- positive, metastatic breast cancer
Final analysis from the DESTINY-
Breast03 trial